Liver injury with dipeptidyl peptidase-4 (DPP-4) inhibitors (GLIPTINS): signals emerging from the us-fda adverse event reporting system

Authors :: Ariola Koci
F. De Ponti
Emanuel Raschi
Ippazio Cosimo Antonazzo
Elisabetta Poluzzi
Source :: Clinical Therapeutics. 37:e106
Publication Year :: 2015
Publisher :: Elsevier BV, 2015.

Subjects :: Pharmacology
Liver injury
Adverse Event Reporting System
business.industry
DPP-4 Inhibitors
medicine
Pharmacology (medical)
medicine.disease
business
Dipeptidyl peptidase-4

Tools